340 related articles for article (PubMed ID: 2319514)
1. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
3. Development of beta-lactamase inhibitors.
Sutherland R
J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
[TBL] [Abstract][Full Text] [Related]
4. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
Maddux MS
Pharmacotherapy; 1991; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
[TBL] [Abstract][Full Text] [Related]
7. Parenteral beta-lactamase inhibitor combinations for clinical use.
Manzella JP
Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
Moittie D; Simonet M; Veron M
Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH
Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032
[TBL] [Abstract][Full Text] [Related]
10. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Grimm H
Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
[TBL] [Abstract][Full Text] [Related]
11. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
Itokazu GS; Danziger LH
Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
[TBL] [Abstract][Full Text] [Related]
12. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
Acar N; Diri MC; Türkyilmaz FR
Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
[TBL] [Abstract][Full Text] [Related]
14. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
15. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
17. Evolution of beta-lactamase inhibitors.
Rolinson GN
Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
[TBL] [Abstract][Full Text] [Related]
18. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]